Full-Time

Mgr Data Engineer

Research Data and Analytics

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Data Engineering
Data & Analytics
Required Skills
Python
Data Science
Apache Spark
SQL
AWS
Databricks
Requirements
  • Doctorate Degree OR
  • Master’s degree with 4 - 6 years of experience in Computer Science, IT, Computational Chemistry, Computational Biology/Bioinformatics or related field OR
  • Bachelor’s degree with 6 - 8 years of experience in Computer Science, IT, Computational Chemistry, Computational Biology/Bioinformatics or related field OR
  • Diploma with 10 - 12 years of experience in Computer Science, IT, Computational Chemistry, Computational Biology/Bioinformatics or related field
  • Proficiency in SQL and Python for data engineering, test automation frameworks (pytest), and scripting tasks
  • Hands on experience with big data technologies and platforms, such as Databricks, Apache Spark (PySpark, SparkSQL), workflow orchestration, performance tuning on big data processing
  • Excellent problem-solving skills and the ability to work with large, complex datasets
  • Able to engage with business collaborators and mentor team to develop data pipelines and data models
Responsibilities
  • Lead, manage, and mentor a high-performing team of data engineers
  • Design, develop, and implement data pipelines, ETL processes, and data integration solutions
  • Take ownership of data pipeline projects from inception to deployment, manage scope, timelines, and risks
  • Develop and maintain data models for biopharma scientific data, data dictionaries, and other documentation to ensure data accuracy and consistency
  • Optimize large datasets for query performance
  • Collaborate with global multi-functional teams including research scientists to understand data requirements and design solutions that meet business needs
  • Implement data security and privacy measures to protect sensitive data
  • Leverage cloud platforms (AWS preferred) to build scalable and efficient data solutions
  • Collaborate with Data Architects, Business SMEs, Software Engineers and Data Scientists to design and develop end-to-end data pipelines to meet fast paced business needs across geographic regions
  • Identify and resolve data-related challenges
  • Adhere to best practices for coding, testing, and designing reusable code/component
  • Explore new tools and technologies that will help to improve ETL platform performance
  • Participate in sprint planning meetings and provide estimations on technical implementation
Desired Qualifications
  • 3+ years of experience in implementing and supporting biopharma scientific research data analytics (software platforms)
  • A passion for tackling complex challenges in drug discovery with technology and data
  • Good understanding of data modeling, data warehousing, and data integration concepts
  • Good experience using RDBMS (e.g. Oracle, MySQL, SQL server, PostgreSQL)
  • Knowledge of cloud data platforms (AWS preferred)
  • Experience with data visualization tools (e.g. Dash, Plotly, Spotfire)
  • Experience with diagramming and collaboration tools such as Miro, Lucidchart or similar tools for process mapping and brainstorming
  • Experience writing and maintaining technical documentation in Confluence
  • Understanding of data governance frameworks, tools, and best practices
  • Databricks Certified Data Engineer Professional preferred

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective therapeutic solutions and expanding its pipeline of potential new treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.